These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26137913)

  • 1. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.
    Cui D; Zhang C; Liu B; Shu Y; Du T; Shu D; Wang K; Dai F; Liu Y; Li C; Pan F; Yang Y; Ni J; Li H; Brand-Saberi B; Guo P
    Sci Rep; 2015 Jul; 5():10726. PubMed ID: 26137913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer.
    Wang K; Ruan J; Qian Q; Song H; Bao C; Zhang X; Kong Y; Zhang C; Hu G; Ni J; Cui D
    J Nanobiotechnology; 2011 May; 9():23. PubMed ID: 21612621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
    Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
    Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
    Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
    Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGr1-Ag/37LRP promotes growth and proliferation of gastric cancer in vitro and in vivo.
    Liu L; Sun L; Wu K; Shi Y; Wang Y; Wang Y; Zhang N; Zhang H; Zhang H
    Cancer Gene Ther; 2014 Sep; 21(9):355-63. PubMed ID: 25060631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
    Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
    Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
    Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
    Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
    Chen Y; Sun L; Guo D; Wu Z; Chen W
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
    Yuan W; Chen Z; Chen Z; Wu S; Guo J; Ge J; Yang P; Huang J
    Neoplasma; 2012; 59(1):105-13. PubMed ID: 22103904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.
    Akhtar J; Wang Z; Yu C; Zhang ZP
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1685-91. PubMed ID: 24720379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lentiviral vector-mediated Nanog short-hairpin RNA inhibits the growth of human gastric carcinoma xenograft in nude mice].
    Li K; Jiang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):18-22. PubMed ID: 25575052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
    Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
    Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
    Guo S; Tschammer N; Mohammed S; Guo P
    Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.